Post by Merck Life Science

Today, we announced a definitive agreement for the proposed acquisition of Bio-Techne. The proposed acquisition marks an important step in advancing our strategy and strengthening our position across some of the fastest-growing areas of life science, including proteomics, multi-omics, spatial biology, precision diagnostics, and cell and gene therapy. Once completed, the proposed acquisition would bring Bio-Techne's highly complementary capabilities technologies and deep scientific expertise across life science tools, analytical technologies, and next-generation biology to our portfolio. Through this planned acquisition, we would further strengthen our capabilities, accelerate innovation, and support our customers across the scientific journey, from insights and discovery through development and manufacturing, while helping them navigate increasingly complex environments. Read more here: http://ms.spr.ly/6043vUQ8R